Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy begins at a low dose and increases gradually over weeks to help your body adapt to the medication. Most patients follow a standard four-week titration schedule, but the timing and magnitude of dose increases depend on your individual tolerance, weight loss response, and clinical goals. Understanding when and why your dose might increase helps you prepare mentally and physically for your weight loss journey.
How Semaglutide Dosing Works: The Titration Protocol
Semaglutide injection therapy starts at 0.25 mg once weekly, a dose chosen to allow your gastrointestinal system to adjust gradually. After one week at this dose, your prescriber evaluates your tolerance—side effects like mild nausea or reduced appetite are expected and often decrease as your body adapts. The standard protocol increases your dose by 0.25 mg every four weeks until reaching 1.0 mg weekly, a dose proven effective for sustained weight loss in clinical trials.
Your dose may increase beyond the standard 1.0 mg maintenance dose depending on your individual response and treatment goals. Some patients benefit from 1.7 mg or 2.4 mg weekly, doses used in clinical research for people with diabetes and obesity. PlexusDx providers assess your progress at each interval and recommend dose escalation only when medically appropriate, ensuring you receive the minimum effective dose for your unique metabolism and health profile.
Signs Your Semaglutide Dose May Need to Increase
If you've been on your current semaglutide dose for four weeks and experience steady weight loss with manageable side effects, you're a candidate for a dose increase. Plateaus in weight loss lasting more than two consecutive weeks despite consistent diet and exercise effort often signal that your body has adapted to the current dose and requires escalation. Your prescriber will also consider your appetite suppression level—inadequate appetite control suggests your nervous system may benefit from additional GLP-1 receptor stimulation.
Diminishing side effects like nausea or reduced appetite, while sometimes welcome, can indicate your body has become tolerant to your current dose. A return to baseline hunger levels or cravings after weeks of appetite suppression is a clinical signal that dose optimization is needed. PlexusDx providers use these markers alongside your weight loss trajectory to create a personalized titration plan, ensuring your dose increases align with your metabolic needs rather than following a one-size-fits-all calendar.
When to Hold or Delay Dose Increases in Semaglutide Treatment
Persistent side effects that interfere with daily life—severe nausea, vomiting, or dehydration—warrant delaying your next dose increase until symptoms resolve. Some patients benefit from staying at their current dose for an additional two to four weeks, allowing continued weight loss while side effects naturally diminish. Dose increases should always enhance your quality of life, not compromise it; your prescriber will pause escalation if gastrointestinal tolerance remains challenging.
Medical events or life circumstances may also delay dose progression. Illness, surgery, significant dietary changes, or pregnancy considerations require careful assessment before advancing your semaglutide dose. PlexusDx providers review your complete health picture at each visit, ensuring dose timing supports your overall wellness goals and doesn't create unnecessary burden during transitional periods.
PlexusDx Transparent Pricing: Dose Increases Don't Change Your Monthly Cost
PlexusDx Compounded Semaglutide Injection starts at $149 per month, a flat price that remains constant whether your dose is 0.25 mg or 2.4 mg weekly. This pricing model eliminates the financial stress of dose optimization and ensures you're never penalized for needing higher medication strength to reach your health goals. Your dose may increase; your price won't, reflecting PlexusDx's commitment to transparent, predictable weight loss treatment.
Beyond flat-rate semaglutide pricing, PlexusDx offers complementary services to personalize your therapy further. The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and identifies 150+ genetic insights related to weight regulation, including variants in GLP-1 receptor responsiveness. This genetic data helps your provider fine-tune not just your dose, but your entire treatment protocol, maximizing success while keeping your monthly medication cost fixed.
The Role of Genetic Testing in Optimizing Your Semaglutide Dose
Your genetic makeup influences how efficiently your body produces and responds to GLP-1 signaling, the core mechanism behind semaglutide's weight loss effect. PlexusDx Precision Peptide Genetic Test identifies variants in the GLP1R gene (rs6923761) and other peptide-pathway markers that predict your individual dose responsiveness and optimal medication choice. Some people achieve excellent results at lower doses due to genetic factors enhancing receptor sensitivity, while others require higher doses because of genetic variation affecting peptide metabolism.
Understanding your genetic profile before starting dose escalation prevents unnecessary trials of ineffective doses and accelerates your progress toward target weight. PlexusDx providers use this information to recommend not only semaglutide dose timing but also alternative compounds like compounded tirzepatide, which targets additional peptide pathways. Genetic insights transform semaglutide dosing from guesswork into precision medicine, ensuring your treatment aligns with your unique metabolic biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How often does my semaglutide dose increase?
Standard semaglutide titration increases your dose by 0.25 mg every four weeks, assuming you tolerate each level well. PlexusDx providers may adjust this timeline based on your side effects and weight loss response, sometimes extending intervals to four to six weeks for optimal comfort. Your specific schedule is personalized during your initial consultation.
What happens if I don't want to increase my semaglutide dose?
You have the choice to remain at your current dose indefinitely if you're achieving your weight loss goals and feeling well. Some patients reach their target weight on 0.5 mg or 1.0 mg and maintain success without further increases. PlexusDx respects your preferences while ensuring your provider assesses whether continued progress is possible with dose optimization.
Does my monthly price change when my semaglutide dose increases?
No—PlexusDx Compounded Semaglutide Injection is $149 per month flat, regardless of dose level. Your dose may increase from 0.25 mg to 2.4 mg, but your price remains the same, ensuring cost-predictability throughout your treatment journey.
How long does it take to reach the full semaglutide dose?
The standard four-week titration schedule means reaching 1.0 mg maintenance dose takes approximately 16 weeks (four dose increases). If your provider recommends higher doses like 1.7 mg or 2.4 mg, the full protocol may extend to 20-24 weeks total. This gradual approach minimizes side effects and allows sustainable adaptation.
Can genetic testing predict my ideal semaglutide dose?
PlexusDx Precision Peptide Genetic Test identifies GLP1R variants and other weight-regulation genes that influence how responsive you'll be to semaglutide therapy. While the test doesn't predict an exact dose, it reveals whether your genetics favor strong GLP-1 pathway activation or suggest alternative compounds like tirzepatide might be more effective. This insight helps your provider optimize your starting dose and escalation timeline.
What if I'm not losing weight at my current semaglutide dose?
Plateaus lasting more than two weeks warrant a dose increase, provided side effects are manageable. If a higher dose doesn't produce results after another four weeks, PlexusDx providers may recommend switching to a dual-compound option like GLP-Squared Injection, which combines semaglutide with tirzepatide to activate additional metabolic pathways at $249 per month flat.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Stop Taking Ozempic Safely for Weight Loss
Does the Wegovy Pen Hurt? A Guide to a Painless Weight Loss Journey